Identity
- Security key
- 19430
- Ticker
- NVO
- Type
- ADRC — American Depository Receipt Common
- Exchange
- New York Stock Exchange(XNYS)
- Venue group
- NYSE
- Operating MIC
- XNYS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 1981-04-30
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- NVO
Detail
Enriched 2026-08-14 20:47
- Market cap
- $203,241,560,004.72
- Shares outstanding (class)
- 3,390,128,000
- Shares outstanding (weighted)
- 4,381,150,248
- SIC
- —
- Employees
- 69,500
- Location
- —
- Homepage
- https://www.novonordisk.com
- Description
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients with diabetes, as well as injectable and oral GLP-1 therapies, across its obesity and diabetes care segment. Novo also has a rare disease segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Market cap and share counts drift.